IRIS
TOMASSI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.734
NA - Nord America 1.380
EU - Europa 974
SA - Sud America 235
Continente sconosciuto - Info sul continente non disponibili 111
AF - Africa 53
OC - Oceania 2
Totale 4.489
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.327
SG - Singapore 765
RU - Federazione Russa 512
CN - Cina 340
VN - Vietnam 273
IT - Italia 219
BR - Brasile 187
HK - Hong Kong 163
FR - Francia 45
DE - Germania 41
BD - Bangladesh 39
IN - India 36
GB - Regno Unito 29
CI - Costa d'Avorio 28
CA - Canada 25
NL - Olanda 25
JP - Giappone 24
KR - Corea 23
FI - Finlandia 17
MX - Messico 14
PH - Filippine 13
AR - Argentina 12
AT - Austria 12
BG - Bulgaria 12
EC - Ecuador 11
IE - Irlanda 11
CO - Colombia 10
IQ - Iraq 9
PL - Polonia 9
SE - Svezia 9
UA - Ucraina 9
ID - Indonesia 8
TH - Thailandia 8
PK - Pakistan 6
TW - Taiwan 6
BE - Belgio 5
CL - Cile 5
HR - Croazia 5
MA - Marocco 5
ES - Italia 4
JM - Giamaica 4
NP - Nepal 4
PY - Paraguay 4
TR - Turchia 4
ZA - Sudafrica 4
EG - Egitto 3
AU - Australia 2
BB - Barbados 2
ET - Etiopia 2
GR - Grecia 2
IR - Iran 2
MY - Malesia 2
NI - Nicaragua 2
PE - Perù 2
TN - Tunisia 2
UY - Uruguay 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
CG - Congo 1
CH - Svizzera 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
HN - Honduras 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MK - Macedonia 1
MZ - Mozambico 1
NE - Niger 1
NG - Nigeria 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SA - Arabia Saudita 1
SD - Sudan 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
ZM - Zambia 1
Totale 4.379
Salva come PNG Salva come JPEG
Città #
Singapore 378
San Jose 207
Hong Kong 158
Chandler 143
Ashburn 127
Moscow 116
Beijing 99
Ho Chi Minh City 83
Hefei 71
Santa Clara 70
Los Angeles 49
Hanoi 47
The Dalles 38
Lauterbourg 34
Naples 33
Millbury 31
Dallas 26
Boston 23
Des Moines 23
Lawrence 22
Napoli 22
Dong Ket 20
Tokyo 20
Amsterdam 18
Buffalo 18
Council Bluffs 18
Milan 17
São Paulo 17
Redondo Beach 15
Seoul 15
New York 14
Chicago 13
Munich 12
Sofia 12
Wilmington 12
Nanjing 11
Tianjin 11
Kochi 9
Princeton 9
Warsaw 9
Frankfurt am Main 8
Mexico City 8
Ottawa 8
Da Nang 7
Haiphong 7
Nuremberg 7
Porto Alegre 7
Seattle 7
Stockholm 7
Brooklyn 6
Ha Long 6
Memphis 6
Ninh Bình 6
Amorosi 5
Belo Horizonte 5
Biên Hòa 5
Can Tho 5
Denver 5
Florence 5
Lappeenranta 5
London 5
Rio de Janeiro 5
Turku 5
Vienna 5
Zagreb 5
Atlanta 4
Baghdad 4
Brussels 4
Caserta 4
Charlotte 4
Chennai 4
Dhaka 4
Guayaquil 4
Hải Dương 4
Kingston 4
Orem 4
Phoenix 4
Piombino 4
Quito 4
Ribeirão Preto 4
Rome 4
San Francisco 4
Shanghai 4
Toronto 4
Ankara 3
Aversa 3
Bologna 3
Davao City 3
Düsseldorf 3
Florianópolis 3
Hebei 3
Las Vegas 3
Manchester 3
Montreal 3
Mumbai 3
Nanchang 3
Norwalk 3
Querétaro 3
Redwood City 3
Santiago 3
Totale 2.344
Salva come PNG Salva come JPEG
Nome #
Click-Chemistry (CuAAC) Trimerization of an αvβ6 Integrin Targeting Ga-68-Peptide: Enhanced Contrast for in-Vivo PET Imaging of Human Lung Adenocarcinoma Xenografts 185
Exploring the N-Terminal Region of C-X-C Motif Chemokine 12 (CXCL12): Identification of Plasma-Stable Cyclic Peptides As Novel, Potent C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonists 163
Structure-Activity Relationships and Biological Characterization of a Novel, Potent, and Serum Stable C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonist 155
Disulfide bond replacement with 1,4‐ and 1,5‐disubstituted [1,2,3]‐triazole on C‐X‐C chemokine receptor type 4 (CXCR4) peptide ligands: small changes that make big differences 143
A combined approach of structure‐based virtual screening and NMR to interrupt the PD‐1/PD‐L1 axis: Biphenyl‐benzimidazole containing compounds as novel PD‐L1 inhibitors 135
Properly Substituted Cyclic Bis-(2-bromobenzylidene) Compounds Behaved as Dual p300/CARM1 Inhibitors and Induced Apoptosis in Cancer Cells 135
Simultaneous Targeting of RGD-Integrins and Dual Murine Double Minute Proteins in Glioblastoma Multiforme 133
Combined HAT/EZH2 modulation leads to cancer-selective cell death 125
Ligand-Based NMR Study of C-X-C Chemokine Receptor Type 4 (CXCR4)-Ligand Interactions on Living Cancer Cells 124
From a Helix to a Small Cycle: Metadynamics-Inspired αvβ6 Integrin Selective Ligands 124
Identification of PR-SET7 and EZH2 selective inhibitors inducing cell death in human leukemia U937 cells 123
Switchable Protecting Strategy for Solid Phase Synthesis of DNA and RNA Interacting Nucleopeptides 120
Halting the Spread of Herpes Simplex Virus-1: The Discovery of an Effective Dual αvβ6/αvβ8 Integrin Ligand 119
Boosting Fmoc Solid-Phase Peptide Synthesis by Ultrasonication 118
Targeting Drug Resistance in EGFR with Covalent Inhibitors: A Structure-Based Design Approach 118
HOPPI-NMR: Hot-Peptide-Based Screening Assay for Inhibitors of Protein-Protein Interactions by NMR 118
A novel smaller β‐defensin‐derived peptide is active against multidrug‐resistant bacterial strains 112
Investigation of the stereochemical-dependent DNA and RNA binding of arginine-based nucleopeptides 110
Novel Peptide-Based PET Probe for Non-invasive Imaging of C-X-C Chemokine Receptor Type 4 (CXCR4) in Tumors 107
Quinoline-Based p300 Histone Acetyltransferase Inhibitors with Pro-apoptotic Activity in Human Leukemia U937 Cells 104
Characterization of water-soluble esters of nitrobenzoxadiazole-based GSTP1-1 inhibitors for cancer treatment 102
New insights in the structure-activity relationships of 2-phenylamino-substituted benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors 101
From PARP1 to TNKS2 Inhibition: A Structure-Based Approach 99
Indazole-Based Covalent Inhibitors To Target Drug-Resistant Epidermal Growth Factor Receptor. 98
Phenotypic Identification of a Novel Autophagy Inhibitor Chemotype Targeting Lipid Kinase VPS34 98
Discovery of Pyrido[3′,2′:5,6]thiopyrano[4,3‐d]pyrimidine-Based Antiproliferative Multikinase Inhibitors 98
Pan-Histone Demethylase Inhibitors Simultaneously Targeting Jumonji C and Lysine-Specific Demethylases Display High Anticancer Activities 97
Novel reversible monoamine oxidase A inhibitors: highly potent and selective 3-(1H-pyrrol-3-yl)-2-oxazolidinones 95
The organometallic ferrocene exhibits amplified anti-tumor activity by targeted delivery via highly selective ligands to αvβ3, αvβ6, or α5β1 integrins 93
First-in-Class Selective Inhibitors of the Lysine Acetyltransferase KAT8 89
Ultrasound-assisted Peptide Nucleic Acids synthesis (US-PNAS) 79
Disulfide bond replacement with non-reducible side chain to tail macrolactamization for the development of potent and selective CXCR4 peptide antagonists endowed with flanking binding sites 79
Design and synthesis of Nrf2-derived hydrocarbon stapled peptides for the disruption of protein-DNA-interactions 77
Cationic nucleopeptides as novel non-covalent carriers for the delivery of peptide nucleic acid (PNA) and RNA oligomers 74
Switching Roles─Exploring Concentration-Dependent Agonistic versus Antagonistic Behavior of Integrin Ligands 71
Specific Inhibitors of Mitochondrial Deacylase Sirtuin 4 Endowed with Cellular Activity 70
Antitumor efficacy of Kisspeptin in human malignant mesothelioma cells 69
Tailoring the Structure of Cell Penetrating DNA and RNA Binding Nucleopeptides 66
CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists 65
Novel pyridine-containing histone deacetylase inhibitors strongly arrest proliferation, induce apoptosis and modulate miRNAs in cancer cells 64
Irreversible inhibition of TRF2TRFH recruiting functions by a covalent cyclic peptide induces telomeric replication stress in cancer cells 61
Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models 59
tert-Butylcarbamate-Containing Histone Deacetylase Inhibitors: Apoptosis Induction, Cytodifferentiation, and Antiproliferative Activities in Cancer Cells 57
Polycomb Repressive Complex 2 Modulation through the Development of EZH2-EED Interaction Inhibitors and EED Binders 57
Totale 4.489
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.772
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.772
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022167 0 0 2 1 6 19 5 9 12 13 24 76
2022/2023301 37 22 21 11 42 45 2 36 48 20 11 6
2023/2024188 8 30 12 9 5 14 12 39 9 3 34 13
2024/20251.177 56 105 5 15 13 93 136 71 65 124 398 96
2025/20262.267 228 242 245 217 367 48 270 124 229 132 88 77
2026/2027112 65 47 0 0 0 0 0 0 0 0 0 0
Totale 4.489